대장-직장암에서 Cyclooxygenase-2의 발현
Cyclooxygenase-2 Expression in Colorectal Cance
강원경, 천준성, 장세진, 조현민, 천성원, 안창혁, 오승택,
소속 상세정보
강원경 ( Kang Won-Kyung )
가톨릭대학교 의과대학 외과학교실
천준성 ( Cheon Joon-Sung )
가톨릭대학교 의과대학 외과학교실
장세진 ( Jang Seh-Jin )
가톨릭대학교 의과대학 외과학교실
조현민 ( Cho Hyun-Min )
가톨릭대학교 의과대학 외과학교실
천성원 ( Chun Sung-Won )
상쾌한아침외과
안창혁 ( An Chang-Hyeok )
가톨릭대학교 의과대학 외과학교실
오승택 ( Oh Seung-Tack )
가톨릭대학교 의과대학 외과학교실
KMID : 0356720040200020112
Abstract
Purpose: Cyclooxygenase (COX) is an important enzyme that transforms arachidonic acid into prostaglandins and exists as two types of isoenzyme, COX-1 and COX-2. Recently, the expression of COX-2 was presented as an important factor in determining the prognosis in colorectal cancer, and the expressed COX-2 was related with recurrence and liver metastasis after an operation for colorectal cancer. Thus this study was to investigate the relationship between COX-2 expression and the prognosis for colorectal cancer.
Methods: We studied colorectal cancer patients who received operations at the Catholic University of Korea from Jan. 1993 through Dec. 2000, by reviewing their medical records and pathological reports. We used immunohistochemistry to determine the expression rate of COX-2 and to study its relationship with other clinical variables, the disease-free survival rat, and the recurrence rate.
Results: Among the 217 cases, 171 cases (78.8%) showed positive COX-2 expression. The COX-2 expression increased with the differentiation and was lower in cases with lymph-node metastasis. However, no statistically significant difference in age, sex, location of lesion, invasiveness, stage, organ of metastasis, disease-free survival rate, and recurrence existed between patients with positive COX-2 expression and those with negative COX-2 expression.
Conclusions: There is no evidence that COX-2 expression is associated with a poor prognosis for colorectal cancer. J Korean Soc Coloproctol 2004;20:112-117
키워드
대장-직장암;예후
Cyclooxygenase;Colorectal neoplasm;Prognosis
원문 및 링크아웃 정보
등재저널 정보